Topical Ciprofloxacin for Bacterial Corneal Ulcer

Journal of the Medical Association of Thailand

Volumn 83, Issue 7, 2000, Pages 776-782

  Kosrirukvongs, Panida ^a   Buranapongs, Wipawee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bacterial Corneal Ulcer; Topical Ciprofloxacin

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA ULCER; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; CORNEAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REFERENCE VALUES;

EID: 0034218807     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Liesegang TJ. Bacterial keratitis. Infect Dis Clin North Am 1992; 6: 815-29.
2. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology 1981; 88: 814-20.
3. Steinen RF. Current therapy for bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol 1991; 112: 10 S-14 S.
4. Whitcher JP. Corneal ulceration. Int Ophthalmol Clin 1990; 30: 30-2.
5. Kosrirukvongs P, Prabhasawat P, Gherunpong V, Dhiraputra C. Bacterial corneal ulcers at Siriraj Hospital. J Infect Dis Antimicrob Agents 1994; 11: 107-12.
6. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3 per cent ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991; 112 (suppl.): 34S-47S.
7. Cokingtin CD, Hyndiuk RA. Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. Am J Ophthalmol 1991; 112: 25 S-28 S.
8. Chi NX, Neu HC. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984; 25: 319-26.
9. Neu HC. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991; 112(supp.): 15-24.
10. O'Brien TP, Sawusch MR, Dick JD, Gottsch JD. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. Arch Ophthalmol 1988; 106: 1444-6.
11. Insler MS, Fish LA, Silbernagel J, Hobden JA, O'callaghan RJ, Hill JM. Successful treatment of methicillin-resistant Staphylococcus aureus keratitis with topical ciprofloxacin. Ophthalmology 1991; 98: 1690-2.
12. Lauffenburger MD, Cohen KL. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis. Cornea 1993; 12: 517-21.
13. Hooper DC, Wolfson JS, Ng EY, Swartz MN. Mechanisms of action and resistance to ciprofloxacin. Am J Med 1987; 82(suppl 4A): 12-20.
14. Kaatz GW, Seo SM. Mechanism of ciprofloxacin resistance in Pseudomonas aeruginosa. J Infect Dis 1988; 158: 537-41.
15. Alan BDS, Dart JKG. Strategies for the management of microbial keratitis. Br J Ophthalmol 1995; 79: 777-86.
16. McDermott ML, Tran TD, Cowden JW, Buggé CJ L. Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmology 1993; 100: 197-200.
17. Price FW Jr, Whitson WE, Collins KS, Gonzales JS. Corneal tissue levels of topically applied ciprofloxacin. Cornea 1995; 14: 152-6.
18. Borrmann LR, Leopold IH. The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol 1988; 106: 227-9.
19. Lass JH, Mack RJ, Imperia PS, Mallick K, Lazerus HM. An in vitro analysis of aminoglycoside corneal epithelial toxicity. Curr Eye Res 1989; 8: 299-304.
20. Davison CR, Tuft SJ, Dart JKG. Conjunctival necrosis after administration of topical fortified aminoglycosides. Am J Ophthalmol 1991; 111: 690-3.
21. Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3 per cent to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmology 1996; 103: 1854-63.
22. Wilhelmus KR, Hyndiuk RA, Delmar RC, Abshire RL, Folkens AT, Godio LB. 0.3% ciprofloxacin in the treatment of bacterial keratitis. Arch Ophthalmol 1993; 111: 1210-8.
23. Tsai AC, Tseng MC, Chang SW, Hu FR. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J Formos Med Assoc 1995; 94: 760-4.
24. Levey SB, Katz HR, Levine ES, Abrams DA, Marsh MJ. Efficacy of topical ciprofloxacin 0.3% in the treatment of ulcerative keratitis in humans Ann Ophthalmol 1998; 30: 301-4.
25. Parks DJ, Abrams DA, Sarfarazi FA, Katz HR. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993; 115: 471-7.